Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -1.25% | 194.27 | 1.3% | $534.93m | |
| GILD | Gilead Sciences, Inc. | -0.39% | 65.91 | 0.9% | $358.61m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -4.86% | 102.60 | 2.0% | $309.75m | |
| ILMN | Illumina, Inc. | 1.18% | 301.78 | 3.5% | $306.80m | |
| BIIB | Biogen Inc. | -1.43% | 235.30 | 1.3% | $295.43m | |
| CELG | Celgene Corporation | 0.11% | 98.71 | 1.3% | $288.69m | |
| SRPT | Sarepta Therapeutics, Inc. | -2.38% | 82.86 | 14.6% | $174.60m | |
| A | Agilent Technologies, Inc. | 0.55% | 76.82 | 1.6% | $174.30m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -0.80% | 174.60 | 1.9% | $173.15m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -2.09% | 282.09 | 2.6% | $168.99m | |
| EXAS | Exact Sciences Corporation | -1.70% | 105.05 | 24.1% | $132.89m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -3.78% | 40.99 | 13.9% | $110.63m | |
| INCY | Incyte Corporation | -1.39% | 78.00 | 2.5% | $84.52m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.65% | 75.49 | 4.3% | $71.69m | |
| ALDR | Alder Biopharmaceuticals, Inc. | 0.32% | 18.76 | 10.2% | $64.14m |
Company Profile
Adaptimmune Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel cancer immunotherapy products. Its specific peptide enhanced affinity receptor platform enables the engineering of T-cells to target and destroy cancer, including solid tumors. The company was founded by Bent K. Jakobsen, James Julian Noble, and Helena Katrina Tayton-Martin in 2008 and is headquartered in Abingdon, the United Kingdom.